Sign Out
Hypersensitivity to the active substance or to any of the excipients listed in Description.
Pregnancy and breast-feeding (see Precautions and Fertility, pregnancy and lactation under Use in Pregnancy & Lactation).
Pre-existing hypercalcaemia.
Severe renal impairment.
Metabolic bone diseases (including hyperparathyroidism and Paget's disease of the bone) other than primary osteoporosis or glucocorticoid-induced osteoporosis.
Unexplained elevations of alkaline phosphatase.
Prior external beam or implant radiation therapy to the skeleton.
Patients with skeletal malignancies or bone metastases should be excluded from treatment with teriparatide.
